| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/13/1999 | EP0890359A1 Tablets containing beta-lactam antibiotic and process for producing the same |
| 01/13/1999 | EP0890358A1 Soluble, dragée-made chewable tablette containing gum |
| 01/13/1999 | EP0890357A2 Cosmetic and pharmaceutical compositions |
| 01/13/1999 | EP0889738A1 Microparticles, process for their production, and their use in ultrasound diagnosis |
| 01/13/1999 | EP0889730A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation |
| 01/13/1999 | EP0889728A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/13/1999 | EP0889723A1 Transdermal therapeutic system with small application-area thickness and great flexibility, and production process |
| 01/13/1999 | EP0889722A2 Sustained-release preparation and its production |
| 01/13/1999 | EP0889721A1 Remedy for external application, and use of an oil-in-water emulsion for said remedy |
| 01/13/1999 | EP0889710A1 Improvements in or relating to encapsulation |
| 01/13/1999 | EP0797615B1 Polymer microspheres and a method of production thereof |
| 01/13/1999 | EP0712422B1 Method for preparing a gelled aqueous composition and composition thereby obtained |
| 01/13/1999 | CN1204965A Anion exchange resin-containing tablets |
| 01/13/1999 | CN1204959A Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| 01/13/1999 | CN1204525A 'Rukangsan' ointment |
| 01/13/1999 | CN1204513A Lozenge for enriching zinc |
| 01/13/1999 | CN1204510A Stype using gossypol (and) its derivative as active component and use |
| 01/13/1999 | CN1204509A Pharmaceutical aerosol formulation |
| 01/13/1999 | CN1204508A New scleroglucans and cosmetic compositions containing new compounds |
| 01/13/1999 | CN1041600C Process for preparing polyisoprene compound having high content for soft capsules |
| 01/13/1999 | CN1041599C Quick-cold oral liquid for child and preparing method thereof |
| 01/12/1999 | US5859228 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 01/12/1999 | US5859060 Timed release tablet comprising naproxen and pseudoepherine |
| 01/12/1999 | US5859056 Synergistic |
| 01/12/1999 | US5859048 Containing active peptide or protein and tolmetin or salt thereof as mucosal absorption enhancer |
| 01/12/1999 | US5859023 Formulations and compositions of poorly water soluble camptothecin derivatives |
| 01/12/1999 | US5859022 Suspensions in n-methyl-2-pyrrolidinone; for administration to a patient with cancer |
| 01/12/1999 | US5858999 Cosolvent parenteral formulation of tirilazad |
| 01/12/1999 | US5858996 Acrylic polymer, amino tri(lower alkylene phosphonic acid) chelating agent; ophthalmic delivery |
| 01/12/1999 | US5858968 Autoimmune model: insulin not used for its endocrinologic effect (does not affect blood sugar levels), but to damp down the host's autoimmune response and prevent autoimmune destruction of pancreatic beta cells, allowing oral dosing |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858746 Addition polymerization of a water-soluble macromolecular monamer to coat, support, microencapsulate, plug, adhere cells, cell aggregates or tissue |
| 01/12/1999 | US5858531 Blending two incompatible or immiscible polymers, heating to melt the polymers, deformation in a mixer, solidifying, separating and isolating the microparticles first polymer for use as nontoxic medicine carrier, drug delivery |
| 01/12/1999 | US5858413 Contains at least one antacid active substance, sugar or sugar alcohol and water; liquid to semisolid consistency |
| 01/12/1999 | US5858412 Forming aqueous slurry of microcrystalline cellulose and compressibility augmenting agent, drying to form agglomerated particles, adding active agent, incorporating sustained-release carrier |
| 01/12/1999 | US5858411 Obtained by wet granulating aqueous suspension of drug, fine particulate hydroxypropyl methyl cellulose acetate succinate and plasticizer, treating at specified temperature |
| 01/12/1999 | US5858410 Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and rate of solution |
| 01/12/1999 | US5858409 Hydrolyzed cellulose granulations for pharmaceuticals |
| 01/12/1999 | US5858408 Comprising a hydrophobic ointment base, an adhesive substance, an aluminum compound and a drug; remedy of oral diseases, such as periodontal disease |
| 01/12/1999 | US5858407 Method for administering tandospirone |
| 01/12/1999 | US5858406 Blending with electrolyte; eliminates dusting, reduces static charge development when converted to granular, pelletized or tablet form |
| 01/12/1999 | US5858401 Pharmaceutical composition for cyclosporines |
| 01/12/1999 | US5858400 Co-administering an agent having large liposomes that include phospholipids substantially free of sterol |
| 01/12/1999 | US5858398 Microparticles containing active agent, mixture of phospholipids, mixture of nonionic surfactants, sterol suspended in fatty acid |
| 01/12/1999 | US5858397 Liposomal formulations of mitoxantrone |
| 01/12/1999 | US5858395 Solid at ordinary temperatures, becomes liquid having a low viscosity near the skin temperature of humans |
| 01/12/1999 | US5858393 Transdermal patch comprising acrylic adhesive, muscarinic agonist; treating alzheimer*s disease, severe pain; reduced side effects |
| 01/12/1999 | US5858391 Long acting GI and esophageal protectant |
| 01/12/1999 | US5858388 Matrix of ethylene-vinyl acetate copolymer, hydromorphone embedded homogeneously in matrix and biocompatible, non-biodegradable polymer coating |
| 01/12/1999 | US5858385 Microporous hollow fiber membrane having pores filled with water or solvent, fiber lumen filled with solvent or water and pest control substance or fragrance which partitions in pores and diffuses out |
| 01/12/1999 | US5858382 An oil/water emulsion wherein the oil droplets contain a drug in dissolved or dispersed or solubilized form. |
| 01/12/1999 | US5858380 Stable gelled composition with a high electrolyte content |
| 01/12/1999 | US5858375 Pharmaceutical compositions containing D2 O |
| 01/12/1999 | US5858355 Infecting in vitro cultured synovial cells with recombinant viral vector comprising dna sequence encoding interleukin-1 receptor antagonist protein linked to promoter, transplanting cells into arthritic joint space for expression |
| 01/12/1999 | US5858350 Chitin, chitosan |
| 01/12/1999 | US5858344 Oral administration form having acid active substances and a process for its production |
| 01/12/1999 | US5858334 Artificial tanning compositions comprising dihydroxyacetone |
| 01/12/1999 | US5858333 Cationic part containing calcium salt and anionic part containing phosphate salt |
| 01/12/1999 | US5858331 Prilocaine and hydrofluorocarbon aerosol preparations |
| 01/12/1999 | US5858330 Comprising active ingredient, colloidal silica, water, excipients |
| 01/12/1999 | US5858099 Used in chemical or pharmeceutical assaying or manufacturing |
| 01/12/1999 | US5858017 Urologic irrigation solution and method for inhibition of pain, inflammation and spasm |
| 01/12/1999 | CA2164933C Methods for aiding periodontal tissue regeneration |
| 01/12/1999 | CA2138122C Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach and breast cancer |
| 01/12/1999 | CA2104917C Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 01/12/1999 | CA2093282C Intraoral medicament-releasing device |
| 01/12/1999 | CA2070823C Neurologic agents for nasal administration to the brain |
| 01/12/1999 | CA2065809C Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| 01/12/1999 | CA2065652C Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts |
| 01/12/1999 | CA2007823C Low density agglomerate |
| 01/10/1999 | CA2209815A1 Vaccine method using osmotic pump |
| 01/09/1999 | CA2208924A1 Sparing paclitaxel by the use of hyaluronan |
| 01/08/1999 | CA2241305A1 Composition containing lipid vesicles and a crosslinked poly(2-acrylamido-2-methylpropanesulfonic acid) neutralized to at least 90% |
| 01/07/1999 | WO1999000494A2 Cell activation process and reagents therefor |
| 01/07/1999 | WO1999000380A1 Omeprazole sodium salt |
| 01/07/1999 | WO1999000187A1 Hydrophilic polymeric material and method of preparation |
| 01/07/1999 | WO1999000157A1 Device for delivering drug through skin or mucosa |
| 01/07/1999 | WO1999000144A1 Thermodynamic adaptive phased array system for activating thermosensititve liposomes in targeted drug delivery |
| 01/07/1999 | WO1999000142A1 Method for inducing a systemic immune response to a hepatitis or hiv antigen |
| 01/07/1999 | WO1999000134A1 New combination of antiasthma medicaments |
| 01/07/1999 | WO1999000131A1 Novel process for manufacturing paroxetine solid dispersions |
| 01/07/1999 | WO1999000130A1 Method for treating vulvar vestibulitis |
| 01/07/1999 | WO1999000122A1 Method for reducing body weight |
| 01/07/1999 | WO1999000113A1 Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| 01/07/1999 | WO1999000112A1 Sucralfate-containing composition and process for the preparation thereof |
| 01/07/1999 | WO1999000111A1 Proliposome powders for inhalation stabilised by tocopherol |
| 01/07/1999 | WO1999000109A1 Composition comprising a lipoaminoacid and a tannin-rich plant extract |
| 01/07/1999 | WO1999000002A2 Cyclosporin-containing microemulsion preconcentrate composition |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998046270A3 Polymeric conjugates polyvalently presenting an agent for therapy |
| 01/07/1999 | WO1998042321A3 Liquid compositions comprising lamivudine |
| 01/07/1999 | WO1998040049A3 Specific magnetosome, method for the production and use thereof |
| 01/07/1999 | WO1998037872A3 Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use |
| 01/07/1999 | EP0888791A1 Syringe and drug capsule therefor |
| 01/07/1999 | EP0888778A1 Colon selective drug delivery system and compositions comprising said system |
| 01/07/1999 | EP0888773A1 Use of petroselinic acid for the treatment of inflammations of superficial tissues |
| 01/07/1999 | EP0888772A1 Sustained-release metal valproate tablets |
| 01/07/1999 | EP0888771A1 Composition with topical anaesthetic activity |
| 01/07/1999 | EP0888770A1 Compositions comprising cationic polysaccharides and cationic drugs |
| 01/07/1999 | EP0888769A1 Cosmetic compositions containing alkalin alginates lyophilisates |